405 related articles for article (PubMed ID: 17252256)
1. [Therapy of Paget's disease].
Kurth AA
Orthopade; 2007 Feb; 36(2):118, 120-3. PubMed ID: 17252256
[TBL] [Abstract][Full Text] [Related]
2. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
3. [Paget's disease: case report].
Wegierska M; Ignaczak P; Zalewska J; Jeka S
Ann Acad Med Stetin; 2011; 57(3):64-9; discussion 69. PubMed ID: 23383549
[TBL] [Abstract][Full Text] [Related]
4. Management of Paget's disease of bone.
Langston AL; Ralston SH
Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
[TBL] [Abstract][Full Text] [Related]
5. The use of zoledronic acid for Paget's disease of bone.
Maricic M
Curr Osteoporos Rep; 2006 Mar; 4(1):40-4. PubMed ID: 16527007
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and management of Paget's disease of bone.
Ralston SH; Langston AL; Reid IR
Lancet; 2008 Jul; 372(9633):155-163. PubMed ID: 18620951
[TBL] [Abstract][Full Text] [Related]
7. Persistent effect of zoledronic acid in Paget's disease.
Tziomalos K; Florentin M; Krikis N; Perifanis V; Karagiannis A; Harsoulis F
Clin Exp Rheumatol; 2007; 25(3):464-6. PubMed ID: 17631747
[TBL] [Abstract][Full Text] [Related]
8. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
Whitson HE; Lobaugh B; Lyles KW
Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
[TBL] [Abstract][Full Text] [Related]
9. Paget's disease of bone.
Siris ES
J Bone Miner Res; 1998 Jul; 13(7):1061-5. PubMed ID: 9661069
[TBL] [Abstract][Full Text] [Related]
10. Paget's disease of bone: diagnosis and treatment update.
Noor M; Shoback D
Curr Rheumatol Rep; 2000 Feb; 2(1):67-73. PubMed ID: 11123042
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Paget's Disease of Bone with Denosumab: Case Report and Literature Review.
Reid IR; Sharma S; Kalluru R; Eagleton C
Calcif Tissue Int; 2016 Sep; 99(3):322-5. PubMed ID: 27193832
[TBL] [Abstract][Full Text] [Related]
12. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
Al Nofal AA; Altayar O; BenKhadra K; Qasim Agha OQ; Asi N; Nabhan M; Prokop LJ; Tebben P; Murad MH
Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791
[TBL] [Abstract][Full Text] [Related]
13. Zoledronic acid for Paget's disease of bone.
Maricic M
Drugs Today (Barc); 2007 Dec; 43(12):879-85. PubMed ID: 18174973
[TBL] [Abstract][Full Text] [Related]
14. [Intravenous bisphosphonates for bone Paget's disease: higher risk of adverse events].
Grados D; Martínez-Morillo M; Holgado S; Erra A
Med Clin (Barc); 2014 May; 142(10):469-70. PubMed ID: 24120108
[No Abstract] [Full Text] [Related]
15. [Osteitis deformans--Paget's disease].
Sieghart S
Wien Med Wochenschr; 2004; 154(5-6):97-101. PubMed ID: 15106891
[TBL] [Abstract][Full Text] [Related]
16. [Paget's disease of bone-a current review of clinical aspects, diagnostics and treatment].
Klemm P; Dischereit G; von Gerlach S; Lange U
Z Rheumatol; 2021 Feb; 80(1):48-53. PubMed ID: 33005994
[TBL] [Abstract][Full Text] [Related]
17. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy.
Pirih FQ; Zablotsky M; Cordell K; McCauley LK
J Mich Dent Assoc; 2009 May; 91(5):38-43. PubMed ID: 19537656
[TBL] [Abstract][Full Text] [Related]
18. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
Polyzos SA; Anastasilakis AD; Makras P; Terpos E
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
[TBL] [Abstract][Full Text] [Related]
19. Current treatment approaches for Paget's Disease of Bone.
Brandi ML
Discov Med; 2010 Sep; 10(52):209-12. PubMed ID: 20875342
[TBL] [Abstract][Full Text] [Related]
20. [Paget's disease of bone: new therapeutic strategies].
D'Amore M; Lisi S; Sisto M; De Marino AV
Recenti Prog Med; 2013 Mar; 104(3):89-92. PubMed ID: 23548950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
